凋亡信号调节激酶1调控免疫介导的血小板减少症、血栓形成和全身性休克
本研究探讨凋亡信号调节激酶1(ASK1)在免疫复合物(IC)介导的血小板功能及病理中的作用。体外实验使用ASK1特异性抑制剂处理的人血小板及FCGR2A/Ask1-/-转基因小鼠血小板,体内实验采用小鼠模型。结果显示ASK1在FcγRIIA交联后活化,其缺失或抑制可减轻血小板聚集、保护小鼠免于血小板减少症、血栓形成和全身性休克,提示ASK1抑制可能是IC诱导休克及免疫介导血栓性疾病的潜在治疗靶点。
要点
- ASK1存在于人和小鼠血小板中,FcγRIIA交联后在人血小板中活化。
- ASK1缺失或抑制显著减弱抗CD9诱导的血小板聚集,但不影响Syk和PLCγ2活化。
- Ask1缺失保护FCGR2A转基因小鼠免于抗mCD9注射后的血小板减少症、血栓形成和全身性休克。
核心结论
- ASK1抑制可能是治疗IC诱导的休克和其他免疫介导的血栓性疾病的潜在靶点。
研究设计与样本
- 体外使用ASK1特异性抑制剂处理的人血小板及FCGR2A/Ask1-/-转基因小鼠血小板,体内采用小鼠模型研究IC诱导的血小板功能和病理。
主要发现
- ASK1在抗hCD9或IV.3+羊抗鼠交联FcγRIIA后的人血小板中活化。
- 遗传缺失或抑制ASK1显著减弱抗CD9诱导的血小板聚集,但经典FcγRIIA信号靶点Syk和PLCγ2活化不受影响。
- 抗mCD9诱导的cPla2磷酸化和TxA2生成在Ask1缺失转基因小鼠血小板中延迟,导致δ颗粒分泌减少。
- 体内注射抗mCD9后,Ask1缺失保护FCGR2A转基因小鼠免于血小板减少症、血栓形成和全身性休克。
- 全血微流控中,Ask1增强血小板在纤维蛋白原上的黏附和血栓形成。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Immune complexes (ICs) bind to and activate platelets via FcγRIIA, causing patients to experience thrombocytopenia, as well as an increased risk of forming occlusive thrombi. Although platelets have been shown to mediate IC-induced pathologies, the mechanisms involved have yet to be fully elucidated. We identified that apoptosis signal-regulating kinase 1 (ASK1) is present in both human and mouse platelets and potentiates many platelet functions. OBJECTIVES: Here we set out to study ASK1's role in regulating IC-mediated platelet functions in vitro and IC-induced pathologies using an in vivo mouse model. METHODS: Using human platelets treated with an ASK1-specific inhibitor and platelets from FCGR2A/Ask1-/- transgenic mice, we examined various platelet functions induced by model ICs in vitro and in vivo. RESULTS: We found that ASK1 was activated in human platelets following cross-linking of FcγRIIA using either anti-hCD9 or IV.3 + goat-anti-mouse. Although genetic deletion or inhibition of ASK1 significantly attenuated anti-CD9-induced platelet aggregation, activation of the canonical FcγRIIA signaling targets Syk and PLCγ2 was unaffected. We further found that anti-mCD9-induced cPla2 phosphorylation and TxA2 generation is delayed in Ask1 null transgenic mouse platelets leading to diminished δ-granule secretion. In vivo, absence of Ask1 protected FCGR2A transgenic mice from thrombocytopenia, thrombosis, and systemic shock following injection of anti-mCD9. In whole blood microfluidics, platelet adhesion and thrombus formation on fibrinogen was enhanced by Ask1. CONCLUSIONS: These findings suggest that ASK1 inhibition may be a potential target for the treatment of IC-induced shock and other immune-mediated thrombotic disorders.
引用
- Patel P, Shaik NF, Zhou Y, et al. Apoptosis signal-regulating kinase 1 regulates immune-mediated thrombocytopenia, thrombosis, and systemic shock. J Thromb Haemost. 2020. PMID: 32767736. doi:10.1111/jth.15049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。